Skip to main content
Top
Published in: International Journal of Hematology 4/2021

01-04-2021 | Graft-Versus-Host Disease | Original Article

Impact of cGVHD on socioeconomic outcomes in survivors with pediatric hematopoietic stem cell transplant in Japan: a cross-sectional observational study

Authors: Takafumi Soejima, Masaaki Shiohara, Yasushi Ishida, Masami Inoue, Akira Hayakawa, Atsushi Sato, Kiyoko Kamibeppu, Yoshiko Atsuta, Takuya Yamashita

Published in: International Journal of Hematology | Issue 4/2021

Login to get access

Abstract

We conducted a cross-sectional observational study investigating socioeconomic status among Japanese survivors of pediatric hematopoietic stem cell transplantation (HCT) and the impact of chronic graft-versus-host disease (cGVHD) on socioeconomic outcomes, which are topics not well explored in the previous research. We collected data on socioeconomic outcomes from 442 HCT survivors through a questionnaire and obtained demographic and clinical information from their attending physicians and a national database between February 2013 and November 2014. We used logistic regression analysis to examine the relationship between cGVHD and socioeconomic outcomes in allogeneic HCT (allo-HCT) survivors. Most survivors did not experience socioeconomic problems. Nevertheless, allo-HCT survivors with cGVHD aged 8–15 years had poorer economic status (p = 0.013), and allo-HCT survivors with cGVHD aged ≥ 16 years were more likely to have never married (p = 0.034) and less likely to have more than a high school education (p = 0.023), compared with allo-HCT survivors without cGVHD. Thus, cGVHD in Japanese allo-HCT survivors was a risk factor for economic difficulties for those aged 8–15 years, and for never marrying and low educational achievement in those aged ≥ 16 years.
Appendix
Available only for authorised users
Literature
1.
go back to reference D’Souza A, Lee S, Zhu X, Pasquini M. Current use and trends in hematopoietic cell transplantation in the United States. Biol Blood Marrow Transplant. 2017;23(9):1417–21.CrossRef D’Souza A, Lee S, Zhu X, Pasquini M. Current use and trends in hematopoietic cell transplantation in the United States. Biol Blood Marrow Transplant. 2017;23(9):1417–21.CrossRef
2.
go back to reference Copelan EA. Hematopoietic stem-cell transplantation. New Eng J Med. 2006;354(17):1813–26.CrossRef Copelan EA. Hematopoietic stem-cell transplantation. New Eng J Med. 2006;354(17):1813–26.CrossRef
5.
go back to reference Chow EJ, Anderson L, Baker KS, Bhatia S, Guilcher GM, Huang JT, et al. Late effects surveillance recommendations among survivors of childhood hematopoietic cell transplantation: a Children’s Oncology Group report. Biol Blood Marrow Transplant. 2016;22(5):782–95.CrossRef Chow EJ, Anderson L, Baker KS, Bhatia S, Guilcher GM, Huang JT, et al. Late effects surveillance recommendations among survivors of childhood hematopoietic cell transplantation: a Children’s Oncology Group report. Biol Blood Marrow Transplant. 2016;22(5):782–95.CrossRef
6.
go back to reference Socié G, Ritz J. Current issues in chronic graft-versus-host disease. Blood. 2014;124(3):374–84.CrossRef Socié G, Ritz J. Current issues in chronic graft-versus-host disease. Blood. 2014;124(3):374–84.CrossRef
7.
go back to reference Bevans M, El-Jawahri A, Tierney DK, Wiener L, Wood WA, Hoodin F, et al. National Institutes of Health hematopoietic cell transplantation late effects initiative: the patient-centered outcomes working group report. Biol Blood Marrow Transplant. 2017;23(4):538–51.CrossRef Bevans M, El-Jawahri A, Tierney DK, Wiener L, Wood WA, Hoodin F, et al. National Institutes of Health hematopoietic cell transplantation late effects initiative: the patient-centered outcomes working group report. Biol Blood Marrow Transplant. 2017;23(4):538–51.CrossRef
8.
go back to reference Fiuza-Luces C, Simpson RJ, Ramírez M, Lucia A, Berger NA. Physical function and quality of life in patients with chronic GvHD: a summary of preclinical and clinical studies and a call for exercise intervention trials in patients. Bone Marrow Transplant. 2016;51(1):13–26.CrossRef Fiuza-Luces C, Simpson RJ, Ramírez M, Lucia A, Berger NA. Physical function and quality of life in patients with chronic GvHD: a summary of preclinical and clinical studies and a call for exercise intervention trials in patients. Bone Marrow Transplant. 2016;51(1):13–26.CrossRef
9.
go back to reference Effinger KE, Stratton KL, Fisher PG, Ness KK, Krull KR, Oeffinger KC, et al. Long-term health and social function in adult survivors of paediatric astrocytoma: a report from the Childhood Cancer Survivor Study. Eur J Cancer. 2019;106:171–80.CrossRef Effinger KE, Stratton KL, Fisher PG, Ness KK, Krull KR, Oeffinger KC, et al. Long-term health and social function in adult survivors of paediatric astrocytoma: a report from the Childhood Cancer Survivor Study. Eur J Cancer. 2019;106:171–80.CrossRef
10.
go back to reference Frederiksen LE, Mader L, Feychting M, Mogensen H, Madanat-Harjuoja L, Malila N, et al. Surviving childhood cancer: a systematic review of studies on risk and determinants of adverse socioeconomic outcomes. Int J Cancer. 2019;144(8):1796–823.CrossRef Frederiksen LE, Mader L, Feychting M, Mogensen H, Madanat-Harjuoja L, Malila N, et al. Surviving childhood cancer: a systematic review of studies on risk and determinants of adverse socioeconomic outcomes. Int J Cancer. 2019;144(8):1796–823.CrossRef
11.
go back to reference Brinkman TM, Recklitis CJ, Michel G, Grootenhuis MA, Klosky JL. Psychological symptoms, social outcomes, socioeconomic attainment, and health behaviors among survivors of childhood cancer: current state of the literature. J Clin Oncol. 2018;36(21):2190–7.CrossRef Brinkman TM, Recklitis CJ, Michel G, Grootenhuis MA, Klosky JL. Psychological symptoms, social outcomes, socioeconomic attainment, and health behaviors among survivors of childhood cancer: current state of the literature. J Clin Oncol. 2018;36(21):2190–7.CrossRef
12.
go back to reference Gurney JG, Krull KR, Kadan-Lottick N, Nicholson HS, Nathan PC, Zebrack B, et al. Social outcomes in the childhood cancer survivor study cohort. J Clin Oncol. 2009;27(14):2390–5.CrossRef Gurney JG, Krull KR, Kadan-Lottick N, Nicholson HS, Nathan PC, Zebrack B, et al. Social outcomes in the childhood cancer survivor study cohort. J Clin Oncol. 2009;27(14):2390–5.CrossRef
13.
go back to reference Bona K, London WB, Guo D, Abel G, Lehmann L, Wolfe J. Prevalence and impact of financial hardship among New England pediatric stem cell transplantation families. Biol Blood Marrow Transplant. 2015;21(2):312–8.CrossRef Bona K, London WB, Guo D, Abel G, Lehmann L, Wolfe J. Prevalence and impact of financial hardship among New England pediatric stem cell transplantation families. Biol Blood Marrow Transplant. 2015;21(2):312–8.CrossRef
14.
go back to reference Freycon F, Trombert-Paviot B, Casagranda L, Frappaz D, Mialou V, Armari-Alla C, et al. Academic difficulties and occupational outcomes of adult survivors of childhood leukemia who have undergone allogeneic hematopoietic stem cell transplantation and fractionated total body irradiation conditioning. Pediatr Hematol Oncol. 2014;31(3):225–36.CrossRef Freycon F, Trombert-Paviot B, Casagranda L, Frappaz D, Mialou V, Armari-Alla C, et al. Academic difficulties and occupational outcomes of adult survivors of childhood leukemia who have undergone allogeneic hematopoietic stem cell transplantation and fractionated total body irradiation conditioning. Pediatr Hematol Oncol. 2014;31(3):225–36.CrossRef
15.
go back to reference Löf CM, Winiarski J, Ljungman P, Forinder U. The socioeconomic and psychosocial circumstances of adult long-term survivors of hematopoietic stem cell transplantation in childhood. Pediatr Transplant. 2011;15(7):691–8.CrossRef Löf CM, Winiarski J, Ljungman P, Forinder U. The socioeconomic and psychosocial circumstances of adult long-term survivors of hematopoietic stem cell transplantation in childhood. Pediatr Transplant. 2011;15(7):691–8.CrossRef
16.
go back to reference Bhatt NS, Brazauskas R, Tecca HR, Carreras J, Burns LJ, Phelan R, et al. Post-transplantation employment status of adult survivors of childhood allogeneic hematopoietic cell transplant: a report from the Center for International Blood and Marrow Transplant Research (CIBMTR). Cancer. 2019;125(1):144–52.CrossRef Bhatt NS, Brazauskas R, Tecca HR, Carreras J, Burns LJ, Phelan R, et al. Post-transplantation employment status of adult survivors of childhood allogeneic hematopoietic cell transplant: a report from the Center for International Blood and Marrow Transplant Research (CIBMTR). Cancer. 2019;125(1):144–52.CrossRef
17.
go back to reference Ishida Y, Honda M, Ozono S, Okamura J, Asami K, Maeda N, et al. Late effects and quality of life of childhood cancer survivors: part 1. Impact of stem cell transplantation. Int J Hematol. 2010;91(5):865–76.CrossRef Ishida Y, Honda M, Ozono S, Okamura J, Asami K, Maeda N, et al. Late effects and quality of life of childhood cancer survivors: part 1. Impact of stem cell transplantation. Int J Hematol. 2010;91(5):865–76.CrossRef
18.
go back to reference Ishida Y, Honda M, Kamibeppu K, Ozono S, Okamura J, Asami K, et al. Social outcomes and quality of life of childhood cancer survivors in Japan: a cross-sectional study on marriage, education, employment and health-related QOL (SF-36). Int J Hematol. 2011;93(5):633–44.CrossRef Ishida Y, Honda M, Kamibeppu K, Ozono S, Okamura J, Asami K, et al. Social outcomes and quality of life of childhood cancer survivors in Japan: a cross-sectional study on marriage, education, employment and health-related QOL (SF-36). Int J Hematol. 2011;93(5):633–44.CrossRef
19.
go back to reference Ness KK, Mertens AC, Hudson MM, Nagarajan R, Kaste SC, Marina N, et al. Limitations on physical performance and daily activities among long-term survivors of childhood cancer. Ann Intern Med. 2005;143(9):639–47.CrossRef Ness KK, Mertens AC, Hudson MM, Nagarajan R, Kaste SC, Marina N, et al. Limitations on physical performance and daily activities among long-term survivors of childhood cancer. Ann Intern Med. 2005;143(9):639–47.CrossRef
20.
go back to reference Ishida Y, Sato I, Inoue M, Hayakawa A, Shiohara M, Sato A, et al. Quality of life of long-term childhood survivors after autologous or allogeneic stem cell transplantation in Japan—a cross-sectional study [English abstract available]. J Hematop Cell Transplant. 2018;7(3):107–12.CrossRef Ishida Y, Sato I, Inoue M, Hayakawa A, Shiohara M, Sato A, et al. Quality of life of long-term childhood survivors after autologous or allogeneic stem cell transplantation in Japan—a cross-sectional study [English abstract available]. J Hematop Cell Transplant. 2018;7(3):107–12.CrossRef
21.
go back to reference Atsuta Y, Suzuki R, Yoshimi A, Gondo H, Tanaka J, Hiraoka A, et al. Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System. Int J Hematol. 2007;86(3):269–74.CrossRef Atsuta Y, Suzuki R, Yoshimi A, Gondo H, Tanaka J, Hiraoka A, et al. Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System. Int J Hematol. 2007;86(3):269–74.CrossRef
22.
go back to reference Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11(12):945–56.CrossRef Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11(12):945–56.CrossRef
26.
go back to reference Keegan TH, Lichtensztajn DY, Kato I, Kent EE, Wu XC, West MM, et al. Unmet adolescent and young adult cancer survivors information and service needs: a population-based cancer registry study. J Cancer Surviv. 2012;6(3):239–50.CrossRef Keegan TH, Lichtensztajn DY, Kato I, Kent EE, Wu XC, West MM, et al. Unmet adolescent and young adult cancer survivors information and service needs: a population-based cancer registry study. J Cancer Surviv. 2012;6(3):239–50.CrossRef
27.
go back to reference Goldfarb M, Casillas J. Unmet information and support needs in newly diagnosed thyroid cancer: comparison of adolescents/young adults (AYA) and older patients. J Cancer Surviv. 2014;8(3):394–401.CrossRef Goldfarb M, Casillas J. Unmet information and support needs in newly diagnosed thyroid cancer: comparison of adolescents/young adults (AYA) and older patients. J Cancer Surviv. 2014;8(3):394–401.CrossRef
28.
go back to reference Choi SW, Levine JE, Ferrara JL. Pathogenesis and management of graft-versus-host disease. Immunol Allergy Clin N Am. 2010;30(1):75–101.CrossRef Choi SW, Levine JE, Ferrara JL. Pathogenesis and management of graft-versus-host disease. Immunol Allergy Clin N Am. 2010;30(1):75–101.CrossRef
29.
go back to reference Sato I, Higuchi A, Yanagisawa T, Murayama S, Kumabe T, Sugiyama K, et al. Employment status and termination among survivors of pediatric brain tumors: a cross-sectional survey. Int J Clin Oncol. 2018;23(5):801–11.CrossRef Sato I, Higuchi A, Yanagisawa T, Murayama S, Kumabe T, Sugiyama K, et al. Employment status and termination among survivors of pediatric brain tumors: a cross-sectional survey. Int J Clin Oncol. 2018;23(5):801–11.CrossRef
Metadata
Title
Impact of cGVHD on socioeconomic outcomes in survivors with pediatric hematopoietic stem cell transplant in Japan: a cross-sectional observational study
Authors
Takafumi Soejima
Masaaki Shiohara
Yasushi Ishida
Masami Inoue
Akira Hayakawa
Atsushi Sato
Kiyoko Kamibeppu
Yoshiko Atsuta
Takuya Yamashita
Publication date
01-04-2021
Publisher
Springer Singapore
Published in
International Journal of Hematology / Issue 4/2021
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-020-03058-7

Other articles of this Issue 4/2021

International Journal of Hematology 4/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine